logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Retrophin Raises Offer to Acquire Transcept Pharmaceuticals to $4 Per Share

By  +Follow September 19, 2013 8:51AM
Share:
Tickers Mentioned:

Retrophin, Inc. (RTRX) is not giving up on its pursuit to acquire the shares of specialty drug maker Transcept Pharmaceuticals, Inc. (TSPT) that it does not already own.  Last week, Retrophin delivered a letter to the board of directors of Transcept offering to buy the remaining shares for $3.50 each in cash.  The offer was rejected. 

To defend itself from a hostile takeover, Transcept has adopted a shareholder rights plan, often called a “poison pill,” which keeps a shareholder from acquiring more than 4.99 percent of the company.

On Wednesday, Retrophin bumped the offer up to $4.00 per share, with Retrophin chief executive Martin Shkreli sending a letter to the board members of Transcept.

Transcept is focused on development of neuroscience drugs with its only FDA approval being the oral sleep aid Intermezzo (zolpidem tartrate).  Purdue Pharma holds commercialization and development right for Intermezzo in the U.S.  Royalty revenue for Transcept from Intermezzo in the first six months of 2013 was $1.0 million, up from $500,000 in the year prior period. 

Net loss for the six months ended June 30, 2013 was approximately $17.2 million, or $0.92 per share, versus a net loss of approximately $10.3 million, or $0.67 per share, for the six months of 2012.

Retrophin has four drugs in its pipeline with RE-021 the only one in the clinical stage, being researched in a mid-stage trial for Focal Segmental Glomerulosclerosis, a disease that can cause nephrotic syndrome in children and kidney failure in adults.  The company’s other compounds are targeting hard-to-treat diseases like Pantothenate Kinase-Associated Neurodegeneration (PKAN) and Duchenne Muscular Dystrophy.

In recent weeks, three major shareholders of Transcept have publicly stated their disapproval of Transcept’s current strategy.  Activist investor Peter Collery of SC Fundamental LLC, which owns a 6.7-percent stake in Transcept, sent a letter to Transcept chief executive, president and director Glenn Oclassen (read the SEC filing) saying that the company needs to use $60 million of its cash to conduct a share repurchase to build value, not pursue “simply wrongheaded,” (but unnamed) projects.

Collery didn’t hold back much in expressing his feelings toward Transept management.  Such as:

“I should note how troubled we are by your presumption that the company’s money is yours to do with as you see fit. You and your fellow directors have a fiduciary duty to company shareholders.”

And...

“I’d like, in closing, also to express my displeasure with the company’s recent grant of nearly 600,000 management stock options with a strike price of $2.93 per share. As described above, the company’s shares may have a current realizable value of $5 or so. Were Transcept to implement a buyback program, that value might rise to $6. Essentially no management skill would be required to realize these values. That the shares trade for less than $3 is a function of shareholders’ distrust of management. It is incredible that management should be granted undervalued stock options as a “reward” for having created that distrust and I would expect that an inquiry into the deliberations surrounding this recent option grant, and particularly, the suitability of the strike price would be quite interesting.”

Roumell Asset Management, LLC, the largest Transcept shareholder at 12.3 percent of the company, has also filed a 13D with the SEC criticizing the management and demanding a share buy-back plan, not an unidentified acquisition.

The new proposal by Retrophin offers to buy Transcept at a 20-percent premium to Tuesday’s closing price.  The price is still lower than the $6 mark that Collery believes can be attained by performing a share repurchase, but this is a little to-may-toes/to-ma-toes because a merged company could benefit similarly, so investors will have to see where the support falls with the new proposal.

“Our proposal represents an attractive premium to Transcept’s trading performance, and we believe that the proposal offers a compelling opportunity for Transcept’s stockholders, particularly in light of Transcept’s risky and controversial acquisition strategy,” stated Martin Shkreli, Chief Executive Officer of Retrophin. “We hope that Transcept’s Board of Directors will respect its stockholders’ wishes and quickly commence discussions with us regarding the proposed transaction.”

Retrophin wants a transaction to be entered into by the end of September.

Shares of TSPT are down about 18 percent in 2013 thanks to a run-up from lows of $2.52 late in August with the acquisition chatter.  At lows, the stock was off about 40 percent.  Shares rose by 8 percent in Wednesday trading to close at $3.59.  In extended trading, shares rose to $3.98.  Retrophin shares edged up about 1 percent on the day to $6.88.  Shares have more than doubled in 2013.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for rtrx
Pzaa...Guy
31 Oct 14 19:37:05
$RTRX - SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From http://t.co/FBCNmvYYL5
NASDAQ
31 Oct 14 19:37:01
$RTRX - SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From http://t.co/zfAkLoTavO
Stockaholics
31 Oct 14 12:54:22
Our Penny Stock Alerts Gained 250% In 2 days, So far! Big News: http://t.co/bMKiKj7wmb $RTRX $CPST $TGTX
V
31 Oct 14 12:43:17
Bot some $rptp 7.5 and 10 calls added small to my $rtrx position as well ahead of earnings.
Stockaholics
31 Oct 14 12:34:08
Our Penny Stocks Gained 250% In 2 days, So far! Big News: http://t.co/bMKiKj7wmb $RTRX $CPST $TGTX
Stockaholics
31 Oct 14 10:42:55
Our Penny Stock Newsletter Alert On MGON Closed up 112.5% Today! Major News: http://t.co/dvxYQnSJab $RTRX $CPST $TGTX
Stock Relay
31 Oct 14 10:02:19
stockblaster14: Stock Alerts: Retrophin Inc (RTRX) 9.56 $RTRX Retrophin to http://t.co/VGA5AJwQ7h
stockblaster14
31 Oct 14 09:52:37
Retrophin Inc (RTRX) 9.56 $RTRX Retrophin to Report Third Quarter 2014 Financial Results Business Wire - Thu O http://t.co/DwaFRnUaJz
Class Actions News
31 Oct 14 08:10:02
$RTRX sued by investors re CEO alleged unauthorized stock grants http://t.co/fLEffrQXAj
biotechtoreador
31 Oct 14 06:04:02
The perfect $RTRX Halloween costume: http://t.co/lLCFBXy0wE
Zachary Prensky
31 Oct 14 05:30:03
Spotted a short distance from $RTRX Ofc.. Perhaps he's looking to score some free drug? http://t.co/9MYedlc5Sm
Stockaholics
31 Oct 14 02:55:03
Our Penny Stock Newsletter Alert On MGON Closed up 112.5% Today! Major News: http://t.co/gDCrqEFOy6 $RTRX $CPST $TGTX
Stockaholics
30 Oct 14 21:23:27
Our Penny Stock Newsletter Alert On MGON Closed up 112.5% Today! Major News: http://t.co/dvxYQnSJab $RTRX $CPST $TGTX
Stockaholics
30 Oct 14 16:17:13
Our Penny Stock Newsletter Alert On MGON Closed up 112.5% Today! Major News: http://t.co/dvxYQnSJab $RTRX $CPST $TGTX
Jacob Ma-Weaver
30 Oct 14 14:44:02
Amusing misplaced line break...yes investors do need managing sometimes $RTRX "Chris Cline, 646-564-3680 CFA Manager, Investor Relations"
Pzaa...Guy
30 Oct 14 13:31:48
$RTRX - Retrophin to Report Third Quarter 2014 Financial Results http://t.co/5ImUZle0xq
Hung Tran, MS, MD
30 Oct 14 12:00:13
$RTRX $MNKD http://t.co/cvGXAsodN3
Stockaholics
30 Oct 14 11:25:33
VIICQ Closed up 75% Yesterday! Special Update: http://t.co/8A33lxh1RR $RTRX $CPST $TGTX
stockblaster14
30 Oct 14 11:16:14
Retrophin Inc (RTRX) 9.51 $RTRX Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR New http://t.co/M2S3JLXiZg
Option TB
30 Oct 14 10:06:06
Sector update: $RTRX trading -0.53% #options #OptionTradingKungfu--> http://t.co/lvPot3HEB0
BioRunUp
30 Oct 14 06:48:24
RT @bradloncar: $RTRX RT @daviesbj: American Urologic Association not happy with thiola pricing and other Rx shortages http://t.co/FMYmZxOF…
Adam Feuerstein
30 Oct 14 06:47:42
$RTRX RT @daviesbj: American Urologic Association not happy with thiola pricing and other Rx shortages http://t.co/Aoqk04eSA6
Brad Loncar
30 Oct 14 06:47:07
$RTRX RT @daviesbj: American Urologic Association not happy with thiola pricing and other Rx shortages http://t.co/FMYmZxOFhi
Raj R
29 Oct 14 23:28:45
RT @CodesandCiphers: Compare stock performance of biotech mgmt that keeps promises ($TGTX, $BLUE, $ENTA) vs. mgmt that does not ($CRIS, $SR…
Stockaholics
29 Oct 14 20:48:21
$MLCG closed up 166.67% today! Huge News: http://t.co/JxSMla9Afn $RTRX $CPST $TGTX
Stockaholics
29 Oct 14 17:11:38
$MLCG closed up 166.67% today! Huge News: http://t.co/JxSMla9Afn $RTRX $CPST $TGTX
Stockaholics
29 Oct 14 13:10:28
Subscribe to our Penny Stock Newsletter, for the best penny stock picks, for FREE: http://t.co/5DC8vbG515 $RTRX $CPST $TGTX
Stockaholics
29 Oct 14 09:34:59
Subscribe to our Penny Stock Newsletter, for the best penny stock picks, for FREE: http://t.co/5DC8vbG515 $RTRX $CPST $TGTX
V.S. Schulz
29 Oct 14 09:32:40
@ColfaxCapital @dsobek @kokurasluck The ratio of $RTRX / $RGLS share price.
V.S. Schulz
29 Oct 14 08:54:25
.@dsobek @kokurasluck $RGLS $RTRX. At least you have to have had millions to lose millions ;) http://t.co/viKlmalSen
Stockaholics
29 Oct 14 01:55:24
Major New Penny Stock Pick Coming Today! Get The Exclusive First Look: http://t.co/vVXyqlasuZ $RTRX $CPST $TGTX
Stockaholics
28 Oct 14 20:24:58
After 371% Gains Our New Penny Stock Pick Is Coming Tomorrow! Get It Early: http://t.co/Nmnx36zJMR $RTRX $CPST $TGTX
WhiteCoatMafia
28 Oct 14 17:55:09
RT @vram2000: For those still holding $RTRX, email from IR http://t.co/eyEKqrm5fg
Stockaholics
28 Oct 14 16:41:16
After 371% Gains Our New Penny Stock Pick Is Coming Tomorrow! Get It Early: http://t.co/Nmnx36zJMR $RTRX $CPST $TGTX
WhiteCoatMafia
28 Oct 14 15:24:30
@vram2000 The expectations for $RTRX are low right now, as reflected by share price. Low expectations are easy to beat. Tempting to hold.
Stockaholics
28 Oct 14 12:35:15
After 371% Gains A Major New Penny Stock Pick Is Coming: http://t.co/1aBeBJdWkA $RTRX $CPST $TGTX
WhiteCoatMafia
28 Oct 14 11:08:11
@WhiteCoatMafia Now sitting on 34,190 shares $RTRX @ 9.30 avg
WhiteCoatMafia
28 Oct 14 09:15:56
Super low volume $RTRX dip, taking advantage.
Class Actions News
28 Oct 14 06:02:03
$RTRX sued by investors re CEO alleged unauthorized stock grants http://t.co/fLEffrQXAj
wininstocks2014
28 Oct 14 02:16:58
RTRX 9.42 Stock Charts $RTRX Retrophin Inc. (NASDAQ) Last Updated: 10/28/2014 04:17:00 RTRX Stock Chart - 1 Mo http://t.co/DvCRVI8hKT
Stockaholics
28 Oct 14 00:01:33
After 371% Gains A Major New Penny Stock Pick Is Coming: http://t.co/1aBeBJdWkA $RTRX $CPST $TGTX
Stockaholics
27 Oct 14 20:06:44
371% Gains And A New Penny Stock Pick Is Coming Today! Get It Early: https://t.co/jbhQATzxpj $RTRX $CPST $TGTX
ThinkNWaves
27 Oct 14 17:16:19
RT @CodesandCiphers: Compare stock performance of biotech mgmt that keeps promises ($TGTX, $BLUE, $ENTA) vs. mgmt that does not ($CRIS, $SR…
WhiteCoatMafia
27 Oct 14 12:59:11
@WhiteCoatMafia Sold 25000 shares $GERN @ 2.20 (+$1250) to hold 17,500 shares $RTRX @ avg 9.33 for swing up. Still with 76000 GERN @ 2.15
WhiteCoatMafia
27 Oct 14 12:01:55
@WhiteCoatMafia Now with 15000 shares $RTRX @ 9.34 avg
Stockaholics
27 Oct 14 11:52:01
371% Gains And A New Penny Stock Pick Is Coming Today! Get It Early: https://t.co/jbhQATzxpj $RTRX $CPST $TGTX
WhiteCoatMafia
27 Oct 14 10:57:43
@WhiteCoatMafia Added $RTRX around $9.25, now with 9500 shares @ 9.36 avg
WhiteCoatMafia
27 Oct 14 10:31:02
In 6000 shares $RTRX @ 9.41
Codes and Ciphers
27 Oct 14 10:29:05
Compare stock performance of biotech mgmt that keeps promises ($TGTX, $BLUE, $ENTA) vs. mgmt that does not ($CRIS, $SRPT, $RTRX, $ARWR).
WhiteCoatMafia
27 Oct 14 09:44:04
@WhiteCoatMafia All covered $RTRX (+$310)
				
				
By  +Follow September 19, 2013 8:51AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.